Skip to main content

Advertisement

Log in

Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Small cell carcinomas may occur in the thyroid gland. Infrequently, they are primary tumors, and have been interpreted as variants of medullary thyroid carcinoma. However, the vast majority of small cell carcinomas involving the thyroid gland are metastatic tumors. In some cases, demonstration of the primary tumor is not easy. An example of a small cell carcinoma metastatic to the thyroid is presented in this report. The primary tumor was a small cell carcinoma that occurred as a minor component in a transitional carcinoma of the urinary bladder. The microscopical and immunohistochemical features of both tumors, in the thyroid and the bladder, were identical. Moreover, both tumors exhibited an identical mutation in p53, as well as similar loss of heterozygosity at 10q23 and RASSF1A promoter hypermethylation, clearly indicating that the bladder tumor was the site for the primary tumor of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Eusebi V, Damiani S, Riva C, Lloyd RV, Capella C. Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 417:267–71, 1990.

    Article  PubMed  CAS  Google Scholar 

  2. Matias-Guiu X, DeLellis RA, Moley JF. Medullary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumors of endocrine organs: WHO classification of tumors. Lyon: IARC; pp. 86–91, 2004.

    Google Scholar 

  3. Matias-Guiu X, LaGuette J, Puras-Gil AM, Rosai J. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol 21:754–62, 1997.

    Article  PubMed  CAS  Google Scholar 

  4. Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, et al. Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR. J Endocrinol Invest 28:371–8, 2005.

    PubMed  Google Scholar 

  5. Mendelsohn G, Baylin SB, Bigner SH, Wells SA Jr, Eggleston JC. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–41, 1980.

    Article  PubMed  CAS  Google Scholar 

  6. Tsutsumi Y. Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung. Hum Pathol 20:896–902, 1989.

    Article  PubMed  CAS  Google Scholar 

  7. Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 109:364–71, 1988.

    PubMed  CAS  Google Scholar 

  8. Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103:1172–8, 2005.

    Article  PubMed  Google Scholar 

  9. Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–62, 2004.

    Article  PubMed  Google Scholar 

  10. Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 36:718–23, 2005.

    Article  PubMed  CAS  Google Scholar 

  11. Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15:927–34, 1999.

    PubMed  CAS  Google Scholar 

  12. Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25:2001–4, 2005.

    PubMed  CAS  Google Scholar 

  13. Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol 86:213–8, 2005.

    Article  PubMed  Google Scholar 

  14. Gallardo A, Matias-Guiu X, Lagarda H, Catasus L, Bussaglia E, Gras E, et al. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases. Int J Gynecol Pathol 21:268–72, 2002.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xavier Matias-Guiu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puente, S., Velasco, A., Gallel, P. et al. Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder. Endocr Pathol 19, 190–196 (2008). https://doi.org/10.1007/s12022-008-9024-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-008-9024-4

Keywords

Navigation